Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. France Clinical Nutrition Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Route of Administration (Oral, Intravenous)
5.2.2. By Nutrition Type
5.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
5.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
5.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
5.2.4. By End User (Infant & Child, Adults, Geriatrics)
5.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Route of Administration
5.3.2. By Nutrition Type
5.3.3. By Application
5.3.4. By End User
5.3.5. By Substrates
5.3.6. By Region
6. Northern France Clinical Nutrition Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Route of Administration (Oral, Intravenous)
6.2.2. By Nutrition Type
6.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
6.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
6.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
6.2.4. By End User (Infant & Child, Adults, Geriatrics)
6.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
7. Southern France Clinical Nutrition Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Route of Administration (Oral, Intravenous)
7.2.2. By Nutrition Type
7.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
7.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
7.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
7.2.4. By End User (Infant & Child, Adults, Geriatrics)
7.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
8. Western France Clinical Nutrition Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Route of Administration (Oral, Intravenous)
8.2.2. By Nutrition Type
8.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
8.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
8.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
8.2.4. By End User (Infant & Child, Adults, Geriatrics)
8.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
9. Central France Clinical Nutrition Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Route of Administration (Oral, Intravenous)
9.2.2. By Nutrition Type
9.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
9.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
9.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
9.2.4. By End User (Infant & Child, Adults, Geriatrics)
9.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
10. Eastern France Clinical Nutrition Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Route of Administration (Oral, Intravenous)
10.2.2. By Nutrition Type
10.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
10.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
10.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
10.2.4. By End User (Infant & Child, Adults, Geriatrics)
10.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
11. Southwestern France Clinical Nutrition Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Route of Administration (Oral, Intravenous)
11.2.2. By Nutrition Type
11.2.2.1. Enteral Nutrition (Oral Nutrition Supplements, Tube Feeding)
11.2.2.2. Parental Nutrition (Supplemental Parenteral nutrition, Total Parenteral Nutrition; All-in-one system, Multiple bottle system)
11.2.3. By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others)
11.2.4. By End User (Infant & Child, Adults, Geriatrics)
11.2.5. By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants)
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches
14. Policy & Regulatory Landscape
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. France Economic Profile
17. Competitive Landscape
17.1. Business Overview
17.2. Product Offerings
17.3. Recent Developments
17.4. Financials (As Reported)
17.5. Key Personnel
17.6. SWOT Analysis
17.6.1. Nestl? France
17.6.2. Danone SA/France
17.6.3. Abbott France S.A.S.
17.6.4. Fresenius Kabi France
17.6.5. Otsuka Pharmaceutical France SAS
17.6.6. Baxter International Inc.
17.6.7. B. Braun Medical
17.6.8. BASF France SAS
17.6.9. Lonza France
17.6.10. Pfizer
18. Strategic Recommendations